Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.
Benin
Burkina Faso
West Africa
antimicrobial resistance
inequality
low-income countries
qualitative research
Journal
mSystems
ISSN: 2379-5077
Titre abrégé: mSystems
Pays: United States
ID NLM: 101680636
Informations de publication
Date de publication:
30 08 2022
30 08 2022
Historique:
pubmed:
28
7
2022
medline:
28
7
2022
entrez:
27
7
2022
Statut:
ppublish
Résumé
Antimicrobial resistance (AMR) is a global concern that is geographically unevenly distributed, with low- and middle-income countries and African countries suffering in particular. The World Health Organization (WHO) Global Action Plan (GAP) for antimicrobial resistance identified five key objectives that aim to ensure the continued treatment and prevention of infectious diseases with the use of antibiotics. Countries signatory to the WHO GAP are expected to develop their own national action plans (NAPs) based on the global model. How low-income countries are able to achieve the GAP objectives is not well understood. This paper analyzes the progress of two West African countries in achieving the GAP targets, Benin and Burkina Faso, countries among the lowest bracket in the World Development Index. We present qualitative data from interviews and focus group discussions with local policy-makers, nurses, doctors, animal breeders, veterinarians, and laboratory researchers, supported by participant observations and surveys within rural communities. The analysis is organized according to the five WHO GAP objectives to show the countries' challenges in fulfilling them. The analysis shows that there are shortcomings in all of the WHO GAP areas in the two countries, making it a compounded and multifactorial problem-a stacking of lacks. In such contexts, calibrating a society toward AMR resilience/prevention requires overall development and attention to interdependencies. Active local research and policy communities with international, sustained financial support are essential for achieving the targets.
Identifiants
pubmed: 35894597
doi: 10.1128/msystems.00150-22
pmc: PMC9426606
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
e0015022Références
Antimicrob Resist Infect Control. 2020 Aug 28;9(1):145
pubmed: 32859252
BMJ Glob Health. 2019 Aug 15;4(4):e001590
pubmed: 31497315
Glob Health Action. 2019;12(1):1639388
pubmed: 31339473
Afr J Lab Med. 2021 Mar 16;10(1):1157
pubmed: 33824855
Global Health. 2020 Nov 11;16(1):109
pubmed: 33176810
Med Care. 2008 Aug;46(8):847-62
pubmed: 18665065
Antimicrob Resist Infect Control. 2022 Apr 13;11(1):59
pubmed: 35418154
Afr J Lab Med. 2018 Dec 06;7(2):825
pubmed: 30568905
BMC Infect Dis. 2022 Feb 3;22(1):119
pubmed: 35114948
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e565-e568
pubmed: 35224783
BMJ Glob Health. 2020 Sep;5(9):
pubmed: 32967980
Trop Med Int Health. 2021 Oct;26(10):1220-1230
pubmed: 34185935